Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H20N3O4S.Na |
| Molecular Weight | 373.402 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C(=O)N2[C@H]1C([O-])=O
InChI
InChIKey=WQSDWKIPNYFRPW-YWUHCJSESA-M
InChI=1S/C16H21N3O4S.Na/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8;/h3-4,7,9-11,14H,5-6,17H2,1-2H3,(H,18,20)(H,22,23);/q;+1/p-1/t9-,10-,11+,14-;/m1./s1
Epicillin, a penicillin antibiotic, has never been approved in the USA, however, was studied for the treatment of childhood pneumonia, gonorrhea. Epicillin didn’t show any therapeutic advantages for parenteral treatment over ampicillin. By now, ampicillin remains the best-documented drug.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review. | 2008-10-10 |
|
| Identification of penicillin allergenic determinants that bind IgE antibodies in the sera of subjects with penicillin allergy. | 1990-11 |
Patents
Sample Use Guides
oral dose of epicillin in the treatment of gonorrhoea: (a) 2 g epicillin plus 1 g probenecid, (b) 2 g epicillin alone, (c) 1 g epicillin, 1 g cephradine plus 1 g probenecid, and (d) 1 g epicillin and 1 g cephradine.
11 patients with cholelithiasis and choledocholithiasis: were administered i.v.
Route of Administration:
Other
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
59446-81-0
Created by
admin on Wed Apr 02 11:28:44 GMT 2025 , Edited by admin on Wed Apr 02 11:28:44 GMT 2025
|
PRIMARY | |||
|
DTXSID60208166
Created by
admin on Wed Apr 02 11:28:44 GMT 2025 , Edited by admin on Wed Apr 02 11:28:44 GMT 2025
|
PRIMARY | |||
|
23722594
Created by
admin on Wed Apr 02 11:28:44 GMT 2025 , Edited by admin on Wed Apr 02 11:28:44 GMT 2025
|
PRIMARY | |||
|
261-765-6
Created by
admin on Wed Apr 02 11:28:44 GMT 2025 , Edited by admin on Wed Apr 02 11:28:44 GMT 2025
|
PRIMARY | |||
|
5F26232JQ8
Created by
admin on Wed Apr 02 11:28:44 GMT 2025 , Edited by admin on Wed Apr 02 11:28:44 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD